Skip to main content

Table 2 Demographic and clinical characteristics of patients in different groups

From: Phylogenetic analysis and clinical characteristics of the co-occurring mutations in HA and NA genes of influenza A(H1N1)pdm09 viruses during 2015–2017 in Beijing, China

 

Patients with co-occurring mutations in HA and NA (n = 10)

Patients without co-occurring mutations in HA and NA (n = 10)

P

Male sex (%)

4 (40.0)

4 (40.0)

> 0.05

Age (years)

37.5 (16–63)

48 (27–77)

> 0.05

Coexisting disease (%)

3 (30.0)

4 (40.0)

> 0.05

Fever hours

30.0 ± 17.2

37.2 ± 24.3

> 0.05

Max temperature (°C)

39.1 ± 0.5

39.1 ± 0.4

> 0.05

Headache (%)

5 (50.0)

6 (60.0)

> 0.05

Joint and muscular soreness (%)

7 (70.0)

9 (90.0)

> 0.05

Nasal congestion and rhinorrhea (%)

5 (50.0)

6 (60.0)

> 0.05

Sore throat (%)

10 (100.0)

5 (50.0)

< 0.05

Cough (%)

7 (70.0)

10 (100.0)

> 0.05

Expectoration (%)

3 (30.0)

7 (70.0)

> 0.05

Chestpain (%)

2 (20.0)

0 (0.0)

> 0.05

White blood cell counts (× 109/L)

7.6 ± 3.2

6.5 ± 1.2

> 0.05

Neutrophil (%)

71.5 ± 10.7

73.0 ± 8.2

> 0.05

Neutrophil (× 109/L)

5.5 ± 2.6

4.7 ± 1.2

> 0.05

Lymphocyte (%)

17.0 ± 6.3

15.4 ± 5.6

> 0.05

Lymphocyte (× 109/L)

1.2 ± 0.6

1.0 ± 0.4

> 0.05

Monocyte (%)

10.3 ± 5.0

10.9 ± 3.2

> 0.05

Monocyte (× 109/L)

0.8 ± 0.6

0.7 ± 0.2

> 0.05

Hemoglobin(g/L)

136.1 ± 22.9

139.7 ± 12.7

> 0.05

Platelets (× 109/L)

209.5 ± 53.0

205.3 ± 34.7

> 0.05

C-reactive protein (mg/L)

15.7 ± 9.9

21.2 ± 33.2

> 0.05

Pneumonia (%)

0 (0.0)

1 (10.0)

> 0.05